J9030 HCPCS Level II code: Bcg live intravesical instillation, 1 mg
J9030 is the HCPCS code for “Bcg live intravesical instillation, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9030Bcg live intravesical instillation, 1 mg
Short description: Bcg live intravesical 1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9030 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jul 1, 2019
Where J9030 sits
- 1J codesDrugs administered other than orally
- 2Active code J9030Bcg live intravesical instillation, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9030 mean?
J9030 is the HCPCS code for “Bcg live intravesical instillation, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9030?
CMS lists J9030’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9030
All J codesJ9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjsJ9025Injection, azacitidine, 1 mgJ9026Injection, tarlatamab-dlle, 1 mgJ9027Injection, clofarabine, 1 mgJ9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramJ9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic doseJ9031Bcg (intravesical) per instillationJ9032Injection, belinostat, 10 mgJ9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mgJ9034Injection, bendamustine hcl (bendeka), 1 mgJ9035Injection, bevacizumab, 10 mgJ9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg